Familial cancer associated with a polymorphism in ARLTS1

New England Journal of Medicine

Volumn 352, Issue 16, 2005, Pages 1667-1676

  Calin, George Adrian ^a   Trapasso, Francesco ^a   Shimizu, Masayoshi ^a   Dumitru, Calin Dan ^a   Yendamuri, Sai ^a   Godwin, Andrew K ^b   Ferracin, Manuela ^c   Bernardi, Guido ^c   Chatterjee, Devjani ^a   Baldassarre, Gustavo ^d   Rattan, Shashi ^a   Alder, Hansjuerg ^a   Mabuchi, Hideaki ^a   Shiraishi, Takeshi ^a   Hansen, Lise Lotte ^e   Overgaard, Jens ^e   Herlea, Vlad ^f   Mauro, Francesca Romana ^g   Dighiero, Guillaume ^h   Movsas, Benjamin ^b   Rassenti, Laura ⁱ   Kipps, Thomas ⁱ   Baffa, Raffaele ^a   Fusco, Alfredo ^j   Mori, Masaki ^k   Russo, Giandomenico ^l   Liu, Chang Gong ^a   Neuberg, Donna ^m   Bullrich, Florencia ^a   Negrini, Massimo ^a,c   Croce, Carlo M ^a,n   more..

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c UNIVERSITY OF FERRARA   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e AARHUS UNIVERSITY   (Denmark)

^f FUNDENI CLINICAL INSTITUTE   (Romania)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h INSTITUT PASTEUR   (France)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^k KYUSHU UNIVERSITY   (Japan)

^l Istituto di Ricovero e Cura A Carattere Scientifico   (Italy)

^m DANA FARBER CANCER INSTITUTE   (United States)

ⁿ OHIO STATE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; DOWN REGULATION; FAMILIAL CANCER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; METHYLATION; NONSENSE MUTATION; PRIORITY JOURNAL; PROMOTER REGION; TUMOR SUPPRESSOR GENE;

ADP-RIBOSYLATION FACTORS; ANIMALS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; CODON, NONSENSE; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GERM-LINE MUTATION; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCYTOPENIA; PEDIGREE; POLYMORPHISM, GENETIC; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS;

EID: 20244379702     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa042280     Document Type: Article

References (29)

1. Bullrich F, Fujii H, Calin G, et al. Characterization of the 13q14 tumor suppressor locus in CLL: identification of ALT1, an alternative splice variant of the LEU2 gene. Cancer Res 2001;61:6640-8.
2. Bullrich F, Croce CM. Molecular biology of chronic lymphocytic leukemia. In: Chenson BD, ed. Chronic lymphoid leukemias. New York: Marcel Dekker, 2001:9-32.
3. LaStarza R, Wlodarska I, Aventin A, et al. Molecular delineation of 13q deletion boundaries in 20 patients with myeloid malignancies. Blood 1998;91:231-7.
4. Yin Z, Spitz MR, Babaian RJ, Strom SS, Troncoso P, Kagan J. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. Oncogene 1999;18:7576-83.
5. Dahlen A, Debiec-Rychter M, Pedeutour F, et al. Clustering of deletions on chromosome 13 in benign and low-malignant lipomatous tumors. Int J Cancer 2003;103:616-23.
6. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-6.
7. Brown AG, Ross FM, Dunne EM, Steel CM, Weir-Thompson EM. Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat Genet 1993;3:67-72.
8. Migliazza A, Bosch F, Komatsu H, et al. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 2001;97:2098-104.
9. Rondeau G, Moreau I, Bezieau S, et al. Comprehensive analysis of a large genomic sequence at the putative B-cell chronic lymphocytic leukaemia (B-CLL) tumour suppressor gene locus. Mutat Res 2001;458:55-70.
10. Mertens D, Wolf S, Schroeter P, et al. Down-regulation of candidate tumor suppressor genes within chromosome band 13q14.3 is independent of the DNA methylation pattern in B-cell chronic lymphocytic leukemia. Blood 2002;99:4116-21.
11. Mabuchi H, Fujii H, Calin G, et al. Cloning and characterization of CLLD6, CLLD7, and CLLD8, novel candidate genes for leukemogenesis at chromosome 13q14, a region commonly deleted in B-cell chronic lymphocytic leukemia. Cancer Res 2001;61:2870-7.
12. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9.
13. Sambrook J, Frisch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1989.
14. Bullrich F, Veronese ML, Kitada S, et al. Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 1996;88:3109-15.
15. Ghosh K, Ghosh HP. Role of the membrane anchoring and cytoplasmic domains in intracellular transport and localization of viral glycoproteins. Biochem Cell Biol 1999;77:165-78.
16. Frommer M, McDonald LE, Millar DS, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992;89:1827-31.
17. Ramakrishnan R, Dorris D, Lublinsky A, et al. An assessment of Motorola CodeLink microarray performance for gene expression profiling applications. Nucleic Acids Res 2002;30:e30.
18. Roest Crollius H, Jaillon O, Bernot A, et al. Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence. Nat Genet 2000;25:235-8.
19. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921. [Erratum, Nature 2001;412:565.]
20. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-51. [Erratum, Science 2001;292:1838.]
21. Moss J, Vaughan M. Molecules in the ARF orbit. J Biol Chem 1998;273:21431-4.
22. Kahn RA, Der CJ, Bokoch GM. The ras superfamily of GTP-binding proteins: guidelines on nomenclature. FASEB J 1992;6:2512-3.
23. Houlston RS, Sellick G, Yuille M, Matutes E, Catovsky D. Causation of chronic lymphocytic leukemia - insights from familial disease. Leuk Res 2003;27:871-6.
24. He H, Dai F, Yu L, et al. Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. Gene Expr 2002;10:231-42.
25. Hashimoto S, Onodera Y, Hashimoto A, et al. Requirement for Arf6 in breast cancer invasive activities. Proc Natl Acad Sci U S A 2004;101:6647-52.
26. Goggins M, Schutte M, Lu J, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 1996;56:5360-4.
27. Mazoyer S, Dunning AM, Serova O, et al. A polymorphic stop codon in BRCA2. Nat Genet 1996;14:253-4.
28. Valencia A, Chardin P, Wittinghofer A, Sander C. The ras protein family: evolutionary tree and role of conserved amino acids. Biochemistry 1991;30:4637-48.
29. Abudugupur A, Mitsui K, Yokota S, Tsurugi K. An ARL1 mutation affected autophagic cell death in yeast, causing a defect in central vacuole formation. Cell Death Differ 2002;9:158-68.